首页 > 最新文献

Pediatric Allergy Immunology and Pulmonology最新文献

英文 中文
Everything That Wheezes Is Not Asthma: A Case Report. 所有喘气的东西都不是哮喘:一个病例报告。
IF 0.9 4区 医学 Q4 ALLERGY Pub Date : 2021-09-01 Epub Date: 2021-06-18 DOI: 10.1089/ped.2021.0006
Sagar K Shah, Natalie Sabzghabaei

Background: This case report provides the general pediatrician with insight on a unique presentation of an already rare disease. Plastic bronchitis (PB) is an exceedingly rare disease that presents with the formation of casts in the endobronchial tree. This typically occurs in patients with congenital heart defects that have undergone repair, however, it is atypical to be seen in otherwise healthy patients. Influenza A, lymphatic abnormalities, and single ventricle physiology are the only proven causes of PB. Asthma, toxic inhalation, and acute chest syndrome, however, are a few of the many conditions that have been proposed to predispose patients toward developing PB. Case Presentation: Thus, it is important to discuss the case of a 9-year-old boy with a history of uncontrolled asthma who presented with cough, chills, weight loss, and fevers. This patient was initially treated with broad-spectrum antibiotics due to concerns for necrotizing pneumonia, but due to failure in improvement, a direct laryngoscopy and bronchoscopy was performed, revealing the diagnosis of PB. Although this patient had a history of uncontrolled asthma, this was the only predisposing respiratory condition that put him at risk of developing PB. This patient went on to be treated with corticosteroids, chest physiotherapy, inhaled fibrinolytics, and direct fibrinolytic therapy with marked improvement in symptoms and imaging. Conclusion: PB, though rare, is a condition that all pediatricians must keep in their minds when patients present with respiratory symptoms with an unclear etiology. The delay in diagnosis and treatment of patients with PB can be detrimental as expectoration of these casts can result in asphyxiation and death. This article goes on to remind all providers, at all levels, the importance of conducting a thorough history/physical examination, creating a broad differential, and treating each patient holistically.

背景:本病例报告为儿科医生提供了一种罕见疾病的独特表现。塑性支气管炎(PB)是一种非常罕见的疾病,表现为支气管树内形成铸型。这通常发生在接受过修复的先天性心脏缺陷患者中,然而,在其他健康患者中并不常见。甲型流感、淋巴异常和单心室生理是唯一被证实的PB病因。然而,哮喘、毒性吸入和急性胸综合征是许多已被提出的使患者易患PB的条件中的少数几种。病例介绍:因此,讨论一个9岁男孩的病例是很重要的,他有不受控制的哮喘病史,表现为咳嗽、发冷、体重减轻和发烧。由于担心坏死性肺炎,患者最初使用广谱抗生素治疗,但由于改善失败,进行了直接喉镜和支气管镜检查,诊断为PB。尽管该患者有未控制的哮喘病史,但这是唯一使其有患PB风险的易感呼吸系统疾病。该患者继续接受皮质类固醇、胸部物理治疗、吸入纤维蛋白溶解剂和直接纤维蛋白溶解治疗,症状和影像学明显改善。结论:PB虽然罕见,但当患者出现病因不明的呼吸道症状时,所有儿科医生都必须牢记。对PB患者的诊断和治疗的延误可能是有害的,因为这些铸型的咳痰可导致窒息和死亡。这篇文章继续提醒所有的医生,在所有级别,进行彻底的病史/身体检查,创建一个广泛的鉴别,并全面治疗每个病人的重要性。
{"title":"Everything That Wheezes Is Not Asthma: A Case Report.","authors":"Sagar K Shah,&nbsp;Natalie Sabzghabaei","doi":"10.1089/ped.2021.0006","DOIUrl":"https://doi.org/10.1089/ped.2021.0006","url":null,"abstract":"<p><p><b><i>Background:</i></b> This case report provides the general pediatrician with insight on a unique presentation of an already rare disease. Plastic bronchitis (PB) is an exceedingly rare disease that presents with the formation of casts in the endobronchial tree. This typically occurs in patients with congenital heart defects that have undergone repair, however, it is atypical to be seen in otherwise healthy patients. Influenza A, lymphatic abnormalities, and single ventricle physiology are the only proven causes of PB. Asthma, toxic inhalation, and acute chest syndrome, however, are a few of the many conditions that have been proposed to predispose patients toward developing PB. <b><i>Case Presentation:</i></b> Thus, it is important to discuss the case of a 9-year-old boy with a history of uncontrolled asthma who presented with cough, chills, weight loss, and fevers. This patient was initially treated with broad-spectrum antibiotics due to concerns for necrotizing pneumonia, but due to failure in improvement, a direct laryngoscopy and bronchoscopy was performed, revealing the diagnosis of PB. Although this patient had a history of uncontrolled asthma, this was the only predisposing respiratory condition that put him at risk of developing PB. This patient went on to be treated with corticosteroids, chest physiotherapy, inhaled fibrinolytics, and direct fibrinolytic therapy with marked improvement in symptoms and imaging. <b><i>Conclusion:</i></b> PB, though rare, is a condition that all pediatricians must keep in their minds when patients present with respiratory symptoms with an unclear etiology. The delay in diagnosis and treatment of patients with PB can be detrimental as expectoration of these casts can result in asphyxiation and death. This article goes on to remind all providers, at all levels, the importance of conducting a thorough history/physical examination, creating a broad differential, and treating each patient holistically.</p>","PeriodicalId":54389,"journal":{"name":"Pediatric Allergy Immunology and Pulmonology","volume":"34 3","pages":"119-123"},"PeriodicalIF":0.9,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664116/pdf/ped.2021.0006.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39246189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Serum Level of Squamous Cell Carcinoma Antigen as a Real-Time Biomarker of Atopic Dermatitis. 血清鳞状细胞癌抗原水平作为特应性皮炎的实时生物标志物。
IF 0.9 4区 医学 Q4 ALLERGY Pub Date : 2021-09-01 Epub Date: 2021-08-19 DOI: 10.1089/ped.2021.0049
Masaki Shimomura, Yuka Okura, Yutaka Takahashi, Ichiro Kobayashi

Background: Although serum levels of squamous cell carcinoma antigen (SCCA) are elevated in atopic dermatitis (AD), their clinical utility has not been fully elucidated. Methods: Thirty-three cases of AD who admitted to our hospital were analyzed. Results: Baseline characteristics on admission were as follows: median age 19 months [interquartile range (IQR), 12-52 months], median objective severity scoring of atopic dermatitis (O-SCORAD) 19.2 (IQR, 4.2-36.0), and median serum SCCA levels 3.2 ng/mL (IQR, 2.1-6.8 ng/mL). O-SCORAD significantly correlated with serum SCCA levels (rs = 0.865, P < 0.001). In 9 cases whose information before and after treatment was available (median interval, 3 days; IQR 2-5 days), median serum SCCA levels significantly decreased from 8.0 to 2.0 ng/mL (P = 0.008) after the treatment. Conclusions: Serum levels of total SCCA rapidly declined in response to the treatment and could be used as a real-time biomarker in childhood AD.

背景:虽然血清中鳞状细胞癌抗原(SCCA)水平在特应性皮炎(AD)中升高,但其临床应用尚未完全阐明。方法:对我院收治的33例AD患者进行分析。结果:入院时的基线特征如下:中位年龄19个月[四分位数范围(IQR), 12-52个月],特应性皮炎客观严重程度评分中位数(O-SCORAD) 19.2 (IQR, 4.2-36.0),血清SCCA水平中位数为3.2 ng/mL (IQR, 2.1-6.8 ng/mL)。治疗后O-SCORAD与血清SCCA水平显著相关(rs = 0.865, P = 0.008)。结论:血清总SCCA水平在治疗后迅速下降,可作为儿童AD的实时生物标志物。
{"title":"A Serum Level of Squamous Cell Carcinoma Antigen as a Real-Time Biomarker of Atopic Dermatitis.","authors":"Masaki Shimomura,&nbsp;Yuka Okura,&nbsp;Yutaka Takahashi,&nbsp;Ichiro Kobayashi","doi":"10.1089/ped.2021.0049","DOIUrl":"https://doi.org/10.1089/ped.2021.0049","url":null,"abstract":"<p><p><b><i>Background:</i></b> Although serum levels of squamous cell carcinoma antigen (SCCA) are elevated in atopic dermatitis (AD), their clinical utility has not been fully elucidated. <b><i>Methods:</i></b> Thirty-three cases of AD who admitted to our hospital were analyzed. <b><i>Results:</i></b> Baseline characteristics on admission were as follows: median age 19 months [interquartile range (IQR), 12-52 months], median objective severity scoring of atopic dermatitis (O-SCORAD) 19.2 (IQR, 4.2-36.0), and median serum SCCA levels 3.2 ng/mL (IQR, 2.1-6.8 ng/mL). O-SCORAD significantly correlated with serum SCCA levels (rs = 0.865, <i>P</i> < 0.001). In 9 cases whose information before and after treatment was available (median interval, 3 days; IQR 2-5 days), median serum SCCA levels significantly decreased from 8.0 to 2.0 ng/mL (<i>P</i> = 0.008) after the treatment. <b><i>Conclusions:</i></b> Serum levels of total SCCA rapidly declined in response to the treatment and could be used as a real-time biomarker in childhood AD.</p>","PeriodicalId":54389,"journal":{"name":"Pediatric Allergy Immunology and Pulmonology","volume":"34 3","pages":"102-105"},"PeriodicalIF":0.9,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664118/pdf/ped.2021.0049.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39329432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determining the Best Tool Comparable with Global Initiative for Asthma Criteria for Assessing Pediatric Asthma Control. 确定评估儿童哮喘控制与全球哮喘倡议标准的最佳工具。
IF 0.9 4区 医学 Q4 ALLERGY Pub Date : 2021-09-01 Epub Date: 2021-08-24 DOI: 10.1089/ped.2020.1334
Ayşegül Akan, Emine Dibek Mısırlıoğlu, Ersoy Civelek, Can Naci Kocabaş

Background: Guidelines such as Global Initiative for Asthma (GINA) recommend disease control as the mainstay of asthma management. Objective: To investigate which measure of asthma control best correlates with the GINA criteria for determining asthma control in children. Methods: Child asthma-patients at a tertiary hospital were enrolled in the study after evaluation of response to treatment. Asthma control test (ACT)/pediatric asthma control test (PACT), Pediatric Asthma Quality of Life Questionnaire (PAQLQ), fractional exhaled nitric oxide (FeNO), and lung function parameters were evaluated. Patients were examined by asthma specialists and control status was evaluated based on GINA. Results: The median age (interquartile range) of patients was 10.7 (8.4-12.9) years, 57.9% of patients were boys. Of 228 children, 84.2%, 9.6%, and 6.1% displayed "well-controlled", "partially controlled", and "uncontrolled" asthma, respectively, according to GINA. The patients with "partially controlled" and "uncontrolled" asthma were grouped as "not well-controlled." The cutoff levels were 22, 21, and 5.9 for PACT, ACT, and PAQLQ, respectively, for determining "well-controlled" asthma (P < 0.001). With these cutoff values, ACT exhibited higher comparability with GINA than PACT and PAQLQ (κ = 0.473, 0.221, and 0.150, respectively, P < 0.001). PAQLQ had higher agreement with GINA criteria in children ≥12 years old (κ = 0.326, P < 0.001 and κ = 0.151, P = 0.014, respectively). Correctly classified patients with PACT, ACT, and PALQLQ based on GINA with these cutoff levels were 93 (64.1%), 63 (75.9%), and 139 (62.9%), respectively. FeNO and lung function parameters were unsuccessful at revealing control status according to GINA. Conclusion: ACT is better than PACT for comparability with GINA. Better correlation of PAQLQ and ACT and better comparability of PAQLQ and GINA were evident in older children.

背景:全球哮喘倡议(GINA)等指南建议将疾病控制作为哮喘管理的主要内容。目的:探讨确定儿童哮喘控制的GINA标准与哮喘控制的最佳相关性。方法:对某三级医院的儿童哮喘患者进行治疗效果评价,纳入研究。评估哮喘控制试验(ACT)/儿童哮喘控制试验(PACT)、儿童哮喘生活质量问卷(PAQLQ)、呼气一氧化氮分数(FeNO)和肺功能参数。患者由哮喘专家检查,并根据GINA评估控制状况。结果:患者中位年龄(四分位数间距)为10.7(8.4 ~ 12.9)岁,男孩占57.9%。在228名儿童中,84.2%、9.6%和6.1%分别表现出“良好控制”、“部分控制”和“未控制”的哮喘。“部分控制”和“未控制”的哮喘患者被归为“控制不好”。用于判定“控制良好”哮喘的PACT、ACT和PAQLQ的临界值分别为22、21和5.9 (P P P P分别= 0.014)。基于GINA正确分类PACT、ACT和PALQLQ患者,这些截止水平分别为93(64.1%)、63(75.9%)和139(62.9%)。根据GINA, FeNO和肺功能参数不能显示控制状态。结论:ACT与GINA的可比性优于PACT。PAQLQ与ACT有较好的相关性,PAQLQ与GINA有较好的可比性。
{"title":"Determining the Best Tool Comparable with Global Initiative for Asthma Criteria for Assessing Pediatric Asthma Control.","authors":"Ayşegül Akan,&nbsp;Emine Dibek Mısırlıoğlu,&nbsp;Ersoy Civelek,&nbsp;Can Naci Kocabaş","doi":"10.1089/ped.2020.1334","DOIUrl":"https://doi.org/10.1089/ped.2020.1334","url":null,"abstract":"<p><p><b><i>Background:</i></b> Guidelines such as Global Initiative for Asthma (GINA) recommend disease control as the mainstay of asthma management. <b><i>Objective:</i></b> To investigate which measure of asthma control best correlates with the GINA criteria for determining asthma control in children. <b><i>Methods:</i></b> Child asthma-patients at a tertiary hospital were enrolled in the study after evaluation of response to treatment. Asthma control test (ACT)/pediatric asthma control test (PACT), Pediatric Asthma Quality of Life Questionnaire (PAQLQ), fractional exhaled nitric oxide (FeNO), and lung function parameters were evaluated. Patients were examined by asthma specialists and control status was evaluated based on GINA. <b><i>Results:</i></b> The median age (interquartile range) of patients was 10.7 (8.4-12.9) years, 57.9% of patients were boys. Of 228 children, 84.2%, 9.6%, and 6.1% displayed \"well-controlled\", \"partially controlled\", and \"uncontrolled\" asthma, respectively, according to GINA. The patients with \"partially controlled\" and \"uncontrolled\" asthma were grouped as \"not well-controlled.\" The cutoff levels were 22, 21, and 5.9 for PACT, ACT, and PAQLQ, respectively, for determining \"well-controlled\" asthma (<i>P</i> < 0.001). With these cutoff values, ACT exhibited higher comparability with GINA than PACT and PAQLQ (κ = 0.473, 0.221, and 0.150, respectively, <i>P</i> < 0.001). PAQLQ had higher agreement with GINA criteria in children ≥12 years old (κ = 0.326, <i>P</i> < 0.001 and κ = 0.151, <i>P</i> = 0.014, respectively). Correctly classified patients with PACT, ACT, and PALQLQ based on GINA with these cutoff levels were 93 (64.1%), 63 (75.9%), and 139 (62.9%), respectively. FeNO and lung function parameters were unsuccessful at revealing control status according to GINA. <b><i>Conclusion:</i></b> ACT is better than PACT for comparability with GINA. Better correlation of PAQLQ and ACT and better comparability of PAQLQ and GINA were evident in older children.</p>","PeriodicalId":54389,"journal":{"name":"Pediatric Allergy Immunology and Pulmonology","volume":"34 3","pages":"89-96"},"PeriodicalIF":0.9,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664125/pdf/ped.2020.1334.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39342695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Progressive Multifocal Leukoencephalopathy in Children with Primary and Secondary Immune Deficiency. 原发性和继发性免疫缺陷儿童的进行性多灶性脑白质病。
IF 0.9 4区 医学 Q4 ALLERGY Pub Date : 2021-09-01 Epub Date: 2021-06-17 DOI: 10.1089/ped.2020.1330
Asuman Demirbuğa, Ozge Kaba, Selda Hançerli Törün, Edibe Pembegül Yıldız, Esra Yücel, Ayper Somer

Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease of the central nervous system that is caused by John Cunningham virus (JCV). It occurs almost exclusively in immunosuppressed individuals, for example, patients with AIDS and hematological and lymphoreticular malignancies. In this article, we present a review of the literature and 2 case reports with PML. The first report examines a 15-year-old male (who presented with dedicator of cytokinesis 8 deficiency) who was diagnosed as having PML based on characteristic magnetic resonance imaging (MRI) lesions and a positive PCR for JCV in cerebrospinal fluid. He was transferred for bone marrow transplantation after stabilization with therapy of maraviroc and cidofovir. The second report examines a 6-year-old male who presented with encephalitis and was also diagnosed with AIDS. He was diagnosed with PML and started treatment with cidofovir. His clinical status and MRI findings deteriorated rapidly. In immunosuppressive patients who developed encephalopathy, JCV ought to be considered.

进行性多灶性脑白质病(PML)是由约翰·坎宁安病毒(JCV)引起的一种致命的中枢神经系统脱髓鞘疾病。它几乎只发生在免疫抑制的个体中,例如艾滋病患者和血液和淋巴网状恶性肿瘤患者。在本文中,我们回顾了文献和2例PML病例报告。第一份报告检查了一名15岁男性(表现为细胞分裂献身者8缺乏症),根据特征性磁共振成像(MRI)病变和脑脊液中JCV PCR阳性诊断为PML。经马拉韦洛克和西多福韦治疗病情稳定后,转入骨髓移植。第二份报告检查了一名患有脑炎并被诊断患有艾滋病的6岁男性。他被诊断为PML,并开始用西多福韦治疗。他的临床状况和MRI表现迅速恶化。在发生脑病的免疫抑制患者中,应该考虑JCV。
{"title":"Progressive Multifocal Leukoencephalopathy in Children with Primary and Secondary Immune Deficiency.","authors":"Asuman Demirbuğa,&nbsp;Ozge Kaba,&nbsp;Selda Hançerli Törün,&nbsp;Edibe Pembegül Yıldız,&nbsp;Esra Yücel,&nbsp;Ayper Somer","doi":"10.1089/ped.2020.1330","DOIUrl":"https://doi.org/10.1089/ped.2020.1330","url":null,"abstract":"<p><p>Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease of the central nervous system that is caused by John Cunningham virus (JCV). It occurs almost exclusively in immunosuppressed individuals, for example, patients with AIDS and hematological and lymphoreticular malignancies. In this article, we present a review of the literature and 2 case reports with PML. The first report examines a 15-year-old male (who presented with dedicator of cytokinesis 8 deficiency) who was diagnosed as having PML based on characteristic magnetic resonance imaging (MRI) lesions and a positive PCR for JCV in cerebrospinal fluid. He was transferred for bone marrow transplantation after stabilization with therapy of maraviroc and cidofovir. The second report examines a 6-year-old male who presented with encephalitis and was also diagnosed with AIDS. He was diagnosed with PML and started treatment with cidofovir. His clinical status and MRI findings deteriorated rapidly. In immunosuppressive patients who developed encephalopathy, JCV ought to be considered.</p>","PeriodicalId":54389,"journal":{"name":"Pediatric Allergy Immunology and Pulmonology","volume":"34 3","pages":"109-111"},"PeriodicalIF":0.9,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664112/pdf/ped.2020.1330.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39243632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Annual Respiratory Evaluations in Congenital Central Hypoventilation Syndrome and Changes in Ventilatory Management. 先天性中枢性低通气综合征的年度呼吸评估和通气管理的改变。
IF 0.9 4区 医学 Q4 ALLERGY Pub Date : 2021-09-01 Epub Date: 2021-08-27 DOI: 10.1089/ped.2021.0072
Amit S Shah, Roberta M Leu, Thomas G Keens, Ajay S Kasi

Background: Annual in-hospital respiratory evaluations (AREs) during wakefulness and sleep are recommended to assess ventilatory requirements in patients with congenital central hypoventilation syndrome (CCHS) aged ≥2-3 years based on expert consensus. This study aimed to determine if AREs in patients with CCHS led to changes in ventilatory management. Methods: Retrospective review of patients with CCHS who underwent AREs with or without polysomnography between 2017 and 2019 was conducted. Clinical symptoms, results of AREs, and subsequent changes in ventilatory management were analyzed. Results: We identified 10 patients with CCHS aged 4-20 years. All patients required assisted ventilation (AV) only during sleep delivered by positive pressure ventilation via tracheostomy (n = 7) or diaphragm pacing (n = 3). In total, 7 (70%) patients had abnormal oxygenation and/or ventilation requiring changes in ventilator settings or duration of AV. Six patients required an increase in settings and/or duration of AV, and only 1 patient required a decrease in ventilator settings. Two patients had awake hypercapnia during a routine outpatient visit that improved following increase in ventilator settings and a period of continuous AV. One patient who was previously ventilator-dependent only during sleep was identified to require 16 h per day of AV. All patients (n = 3) who reported symptoms such as headache or oxygen desaturations during sleep required an increase in ventilator settings. Conclusion: We report a high prevalence of changes in AV management following an ARE. Our results demonstrate the importance of regular AREs in patients with CCHS to assess their ventilatory requirements and optimize AV.

背景:根据专家共识,建议在2-3岁以上先天性中央性低通气综合征(CCHS)患者清醒和睡眠期间进行年度住院呼吸评估(AREs),以评估通气需求。本研究旨在确定CCHS患者的AREs是否会导致通气管理的改变。方法:回顾性分析2017 - 2019年接受AREs伴或不伴多导睡眠描记术的CCHS患者。分析临床症状、AREs结果以及随后通气管理的变化。结果:我们确定了10例年龄4-20岁的CCHS患者。所有患者仅在睡眠期间通过气管造口正压通气(n = 7)或膈膜起搏(n = 3)进行辅助通气(AV)。总共有7例(70%)患者有异常氧合和/或通气,需要改变呼吸机设置或室速持续时间。6例患者需要增加设置和/或室速持续时间,只有1例患者需要减少呼吸机设置。两名患者在常规门诊就诊期间出现清醒时的高碳酸血症,在增加呼吸机设置和一段时间的持续室速后改善。一名以前仅在睡眠时依赖呼吸机的患者被确定为每天需要16小时的室速。所有报告在睡眠期间出现头痛或氧不饱和等症状的患者(n = 3)都需要增加呼吸机设置。结论:我们报告了ARE术后AV管理改变的高发率。我们的研究结果表明,在CCHS患者中,定期AREs对于评估其通气需求和优化房颤的重要性。
{"title":"Annual Respiratory Evaluations in Congenital Central Hypoventilation Syndrome and Changes in Ventilatory Management.","authors":"Amit S Shah,&nbsp;Roberta M Leu,&nbsp;Thomas G Keens,&nbsp;Ajay S Kasi","doi":"10.1089/ped.2021.0072","DOIUrl":"https://doi.org/10.1089/ped.2021.0072","url":null,"abstract":"<p><p><b><i>Background:</i></b> Annual in-hospital respiratory evaluations (AREs) during wakefulness and sleep are recommended to assess ventilatory requirements in patients with congenital central hypoventilation syndrome (CCHS) aged ≥2-3 years based on expert consensus. This study aimed to determine if AREs in patients with CCHS led to changes in ventilatory management. <b><i>Methods:</i></b> Retrospective review of patients with CCHS who underwent AREs with or without polysomnography between 2017 and 2019 was conducted. Clinical symptoms, results of AREs, and subsequent changes in ventilatory management were analyzed. <b><i>Results:</i></b> We identified 10 patients with CCHS aged 4-20 years. All patients required assisted ventilation (AV) only during sleep delivered by positive pressure ventilation via tracheostomy (<i>n</i> = 7) or diaphragm pacing (<i>n</i> = 3). In total, 7 (70%) patients had abnormal oxygenation and/or ventilation requiring changes in ventilator settings or duration of AV. Six patients required an increase in settings and/or duration of AV, and only 1 patient required a decrease in ventilator settings. Two patients had awake hypercapnia during a routine outpatient visit that improved following increase in ventilator settings and a period of continuous AV. One patient who was previously ventilator-dependent only during sleep was identified to require 16 h per day of AV. All patients (<i>n</i> = 3) who reported symptoms such as headache or oxygen desaturations during sleep required an increase in ventilator settings. <b><i>Conclusion:</i></b> We report a high prevalence of changes in AV management following an ARE. Our results demonstrate the importance of regular AREs in patients with CCHS to assess their ventilatory requirements and optimize AV.</p>","PeriodicalId":54389,"journal":{"name":"Pediatric Allergy Immunology and Pulmonology","volume":"34 3","pages":"97-101"},"PeriodicalIF":0.9,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664117/pdf/ped.2021.0072.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39357495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Successful Rapid Desensitization to Micafungin in a Pediatric Patient. 成功快速脱敏米卡芬在儿科患者。
IF 0.9 4区 医学 Q4 ALLERGY Pub Date : 2021-09-01 Epub Date: 2020-07-21 DOI: 10.1089/ped.2020.1204
Stephanie L Ward, Michelle C Maciag, Sarah Jones, Joyce Lee, John Lee, Ana Dioun Broyles

Introduction: Echinocandin antifungal medications including micafungin are being used more commonly in the treatment of invasive fungal infections in both pediatric and adult patients. Micafungin is also a first-line therapeutic option for candidemia and antifungal prophylaxis in a variety of clinical settings. Hypersensitivity reactions have not been well described; however, isolated cases have been reported. No cases of desensitization to echinocandins have been previously described. Case Presentation: In this report, we described a 14-year-old female with high-risk pre-B cell acute lymphoblastic leukemia diagnosed with pulmonary aspergillosis. She developed a hypersensitivity reaction to micafungin, which was deemed first-line therapy for the infection. A rapid intravenous desensitization protocol was successfully completed without reactions. The patient completed the remaining 2 months of therapy without reactions. Conclusion: This report outlines the first report of a successful desensitization to micafungin or any echinocandin. This is a safe method of completing antifungal therapy in a patient with echinocandin hypersensitivity and may be considered for other patients with micafungin hypersensitivities.

棘白菌素类抗真菌药物,包括米卡芬宁,在治疗儿童和成人患者的侵袭性真菌感染中越来越常用。在各种临床环境中,Micafungin也是念珠菌和抗真菌预防的一线治疗选择。过敏反应尚未得到很好的描述;然而,也报告了一些孤立的病例。以前没有对棘白菌素脱敏的病例。病例介绍:在这个报告中,我们描述了一个14岁的女性高风险前b细胞急性淋巴细胞白血病诊断为肺曲霉病。她对米卡芬金产生了过敏反应,米卡芬金被认为是治疗感染的一线药物。快速静脉脱敏方案成功完成,无不良反应。患者完成了剩余2个月的治疗,无不良反应。结论:本报告概述了首个成功脱敏的米卡芬宁或任何棘白素的报告。这是一种安全的方法,完成抗真菌治疗的患者与棘白菌素过敏,并可考虑其他患者与米卡芬素过敏。
{"title":"Successful Rapid Desensitization to Micafungin in a Pediatric Patient.","authors":"Stephanie L Ward,&nbsp;Michelle C Maciag,&nbsp;Sarah Jones,&nbsp;Joyce Lee,&nbsp;John Lee,&nbsp;Ana Dioun Broyles","doi":"10.1089/ped.2020.1204","DOIUrl":"https://doi.org/10.1089/ped.2020.1204","url":null,"abstract":"<p><p><b><i>Introduction:</i></b> Echinocandin antifungal medications including micafungin are being used more commonly in the treatment of invasive fungal infections in both pediatric and adult patients. Micafungin is also a first-line therapeutic option for candidemia and antifungal prophylaxis in a variety of clinical settings. Hypersensitivity reactions have not been well described; however, isolated cases have been reported. No cases of desensitization to echinocandins have been previously described. <b><i>Case Presentation:</i></b> In this report, we described a 14-year-old female with high-risk pre-B cell acute lymphoblastic leukemia diagnosed with pulmonary aspergillosis. She developed a hypersensitivity reaction to micafungin, which was deemed first-line therapy for the infection. A rapid intravenous desensitization protocol was successfully completed without reactions. The patient completed the remaining 2 months of therapy without reactions. <b><i>Conclusion:</i></b> This report outlines the first report of a successful desensitization to micafungin or any echinocandin. This is a safe method of completing antifungal therapy in a patient with echinocandin hypersensitivity and may be considered for other patients with micafungin hypersensitivities.</p>","PeriodicalId":54389,"journal":{"name":"Pediatric Allergy Immunology and Pulmonology","volume":"34 3","pages":"106-108"},"PeriodicalIF":0.9,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558086/pdf/ped.2020.1204.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39396075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Independent Lung Ventilation in a Pediatric Patient with a Firearm Injury. 独立肺通气在火器伤儿童中的应用。
IF 0.9 4区 医学 Q4 ALLERGY Pub Date : 2021-09-01 DOI: 10.1089/ped.2021.0054
Muhammed Udurgucu, Hatice Albayrak, Hatice Elif Kinik Kaya, Sertaç Hancıoğlu, Nazik Yener

Background: Chest trauma is uncommon in pediatric patients, however, it may be a cause of significant morbidity and mortality. The type and extent of the injury may lead to ventilation and perfusion problems, therefore, there may be a need for mechanical ventilation. Conclusions: "Independent lung ventilation" may be an appropriate option in selected cases in which the aim is to protect the healthy lung or ventilation cannot be obtained with known mechanical ventilation methods. Case: We presented a pediatric patient followed up in the intensive care unit because of a firearm injury, in whom left lung expansion could not be obtained despite repeated interventions, and independent lung ventilation resulted in success.

背景:胸部创伤在儿科患者中并不常见,然而,它可能是一个重要的发病率和死亡率的原因。损伤的类型和程度可能导致通气和灌注问题,因此,可能需要机械通气。结论:在以保护健康肺为目的或用已知机械通气方法无法获得通气的特定病例中,“独立肺通气”可能是一种合适的选择。病例:我们报告了一名因火器伤害而在重症监护室随访的儿科患者,尽管多次干预,左肺扩张仍无法获得,独立肺通气取得成功。
{"title":"Independent Lung Ventilation in a Pediatric Patient with a Firearm Injury.","authors":"Muhammed Udurgucu,&nbsp;Hatice Albayrak,&nbsp;Hatice Elif Kinik Kaya,&nbsp;Sertaç Hancıoğlu,&nbsp;Nazik Yener","doi":"10.1089/ped.2021.0054","DOIUrl":"https://doi.org/10.1089/ped.2021.0054","url":null,"abstract":"<p><p><b><i>Background:</i></b> Chest trauma is uncommon in pediatric patients, however, it may be a cause of significant morbidity and mortality. The type and extent of the injury may lead to ventilation and perfusion problems, therefore, there may be a need for mechanical ventilation. <b><i>Conclusions:</i></b> \"Independent lung ventilation\" may be an appropriate option in selected cases in which the aim is to protect the healthy lung or ventilation cannot be obtained with known mechanical ventilation methods. <b><i>Case:</i></b> We presented a pediatric patient followed up in the intensive care unit because of a firearm injury, in whom left lung expansion could not be obtained despite repeated interventions, and independent lung ventilation resulted in success.</p>","PeriodicalId":54389,"journal":{"name":"Pediatric Allergy Immunology and Pulmonology","volume":"34 3","pages":"112-114"},"PeriodicalIF":0.9,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664120/pdf/ped.2021.0054.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39396074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
X-Linked Agammaglobulinemia and COVID-19: Two Case Reports and Review of Literature. x连锁无球蛋白血症与COVID-19:两例报告及文献综述
IF 0.9 4区 医学 Q4 ALLERGY Pub Date : 2021-09-01 DOI: 10.1089/ped.2021.0002
Fiji Madona Devassikutty, Abhinav Jain, Athulya Edavazhippurath, Michael Chittettu Joseph, Mohammed Manakkattu Thekke Peedikayil, Vinod Scaria, Pulukool Sandhya, Geeta Madathil Govindaraj

Introduction: The Centers for Disease Control and Prevention (CDC) has listed primary immunodeficiency disorders as being predisposed to severe coronavirus disease 2019 (COVID-19). However, patients affected with X-linked agammaglobulinemia (XLA) have shown contrary results. In this study, we present 2 boys in late adolescence from south India with XLA who were infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as a review of cases reported in the literature. Case Presentation: Two patients with XLA had been diagnosed late and were started on regular immunoglobulin prophylaxis only during adolescence. Both of them had developed bronchiectasis, an irreversible suppurative lung disease. However, both patients made an uneventful recovery without the need for artificial ventilation or convalescent plasma. Conclusion: Successful outcomes of patients with XLA and COVID-19, except for delayed recovery, from our experience and from global reports are intriguing and the role of B cell depletion is being studied as well. Further research and clinical experience are necessary to fully elucidate the reasons for these observations.

简介:美国疾病控制与预防中心(CDC)已将原发性免疫缺陷疾病列为易患2019年严重冠状病毒病(COVID-19)的人群。然而,患有x连锁无球蛋白血症(XLA)的患者显示出相反的结果。在这项研究中,我们报告了来自印度南部的2名患有XLA的青春期晚期男孩,他们感染了严重急性呼吸综合征冠状病毒2 (SARS-CoV-2),并对文献报道的病例进行了回顾。病例介绍:两例XLA患者诊断较晚,仅在青春期开始常规免疫球蛋白预防。他们两人都患上了支气管扩张症,这是一种不可逆的化脓性肺病。然而,两名患者均顺利康复,无需人工通气或恢复期血浆。结论:从我们的经验和全球报告来看,XLA和COVID-19患者的成功结果,除了延迟恢复外,是有趣的,B细胞耗竭的作用也正在研究中。需要进一步的研究和临床经验来充分阐明这些观察结果的原因。
{"title":"X-Linked Agammaglobulinemia and COVID-19: Two Case Reports and Review of Literature.","authors":"Fiji Madona Devassikutty,&nbsp;Abhinav Jain,&nbsp;Athulya Edavazhippurath,&nbsp;Michael Chittettu Joseph,&nbsp;Mohammed Manakkattu Thekke Peedikayil,&nbsp;Vinod Scaria,&nbsp;Pulukool Sandhya,&nbsp;Geeta Madathil Govindaraj","doi":"10.1089/ped.2021.0002","DOIUrl":"https://doi.org/10.1089/ped.2021.0002","url":null,"abstract":"<p><p><b><i>Introduction:</i></b> The Centers for Disease Control and Prevention (CDC) has listed primary immunodeficiency disorders as being predisposed to severe coronavirus disease 2019 (COVID-19). However, patients affected with X-linked agammaglobulinemia (XLA) have shown contrary results. In this study, we present 2 boys in late adolescence from south India with XLA who were infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as a review of cases reported in the literature. <b><i>Case Presentation:</i></b> Two patients with XLA had been diagnosed late and were started on regular immunoglobulin prophylaxis only during adolescence. Both of them had developed bronchiectasis, an irreversible suppurative lung disease. However, both patients made an uneventful recovery without the need for artificial ventilation or convalescent plasma. <b><i>Conclusion:</i></b> Successful outcomes of patients with XLA and COVID-19, except for delayed recovery, from our experience and from global reports are intriguing and the role of B cell depletion is being studied as well. Further research and clinical experience are necessary to fully elucidate the reasons for these observations.</p>","PeriodicalId":54389,"journal":{"name":"Pediatric Allergy Immunology and Pulmonology","volume":"34 3","pages":"115-118"},"PeriodicalIF":0.9,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664121/pdf/ped.2021.0002.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39396077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome Manifesting as Lymphocytic Interstitial Pneumonia and Treatment-Resistant Bullous Pemphigoid. 以淋巴细胞间质性肺炎和难治性大疱性类天疱疮为表现的免疫失调、多内分泌病、肠病、x连锁综合征。
IF 0.9 4区 医学 Q4 ALLERGY Pub Date : 2021-06-01 DOI: 10.1089/ped.2020.1307
Stine Maria Andersen, Simon Fage, Sune Leisgaard Rubak, Mette Holm, Jens Magnus Bernth Jensen, Trine Mogensen, Mette Deleuran

Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is a rare immune deficiency with a broad clinical presentation. IPEX syndrome causes dysfunctional regulatory T cells, increasing the risk of autoimmune diseases. In this case report, we describe a 7-year-old boy with lymphocytic interstitial pneumonia and bullous pemphigoid who was recently diagnosed with IPEX syndrome.

免疫失调、多内分泌病、肠病、x连锁综合征是一种罕见的免疫缺陷,具有广泛的临床表现。IPEX综合征导致调节性T细胞功能失调,增加自身免疫性疾病的风险。在这个病例报告中,我们描述了一个患有淋巴细胞间质性肺炎和大疱性类天疱疮的7岁男孩,他最近被诊断为IPEX综合征。
{"title":"Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome Manifesting as Lymphocytic Interstitial Pneumonia and Treatment-Resistant Bullous Pemphigoid.","authors":"Stine Maria Andersen,&nbsp;Simon Fage,&nbsp;Sune Leisgaard Rubak,&nbsp;Mette Holm,&nbsp;Jens Magnus Bernth Jensen,&nbsp;Trine Mogensen,&nbsp;Mette Deleuran","doi":"10.1089/ped.2020.1307","DOIUrl":"https://doi.org/10.1089/ped.2020.1307","url":null,"abstract":"<p><p>Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is a rare immune deficiency with a broad clinical presentation. IPEX syndrome causes dysfunctional regulatory T cells, increasing the risk of autoimmune diseases. In this case report, we describe a 7-year-old boy with lymphocytic interstitial pneumonia and bullous pemphigoid who was recently diagnosed with IPEX syndrome.</p>","PeriodicalId":54389,"journal":{"name":"Pediatric Allergy Immunology and Pulmonology","volume":"34 2","pages":"76-79"},"PeriodicalIF":0.9,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329723/pdf/ped.2020.1307.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39244579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Multilevel Airway Stenosis Being Bypassed by a Customized Tracheostomy Tube in an Infant with Myhre Syndrome. 定制气管造瘘管在Myhre综合征婴儿中绕过多节段气道狭窄。
IF 0.9 4区 医学 Q4 ALLERGY Pub Date : 2021-06-01 DOI: 10.1089/ped.2021.0029
Min Jin Jeon, Min Jung Kim, Ji Hye Kim, Ji Soo Park, Jisook Yim, Myungshin Kim, Seong Keun Kwon, Soyoung Lee, Jung Min Ko, Jong-Hee Chae, Dong In Suh

Background: Myhre syndrome is a rare connective tissue disorder caused by heterozygous pathogenic variants in the SMAD4 gene. Although recognizing Myhre syndrome in early childhood is challenging, it is important to manage airway stenosis in patients with Myhre syndrome. Case Presentation: We report the case of a 2-month-old boy who initially presented with severe multilevel airway stenosis, dysmorphic face, and multiple abnormalities. Lung fibrosis and mild aortic valve stenosis were additionally observed on follow-up examinations. A heterozygous missense variant, c.1499T>C (p.Ile500Thr), in SMAD4 was identified through exome sequencing. Tracheostomy was performed, and the patient has maintained stable respiration through a customized tracheostomy tube with a home ventilator. Conclusions: Patients who have dysmorphic face, airway stenosis, and cardiovascular anomalies that do not fit the diagnosis of common syndromes should be evaluated for rare diseases, including Myhre syndrome. Since respiratory complications can be life threatening, early diagnosis and suitable intervention are necessary.

背景:Myhre综合征是一种罕见的结缔组织疾病,由SMAD4基因的杂合致病性变异引起。虽然在儿童早期识别Myhre综合征是具有挑战性的,但对Myhre综合征患者气道狭窄的管理是重要的。病例介绍:我们报告了一个2个月大的男孩,他最初表现为严重的多水平气道狭窄,面部畸形和多种异常。在随访检查中还观察到肺纤维化和轻度主动脉瓣狭窄。通过外显子组测序,鉴定出SMAD4的杂合错义变异C . 1499t >C (p.i ile500thr)。行气管造口术,患者通过定制的气管造口管和家用呼吸机保持呼吸稳定。结论:面部畸形、气道狭窄、心血管异常不符合常见综合征诊断的患者应纳入罕见病评估,包括Myhre综合征。由于呼吸系统并发症可能危及生命,因此早期诊断和适当干预是必要的。
{"title":"Multilevel Airway Stenosis Being Bypassed by a Customized Tracheostomy Tube in an Infant with Myhre Syndrome.","authors":"Min Jin Jeon,&nbsp;Min Jung Kim,&nbsp;Ji Hye Kim,&nbsp;Ji Soo Park,&nbsp;Jisook Yim,&nbsp;Myungshin Kim,&nbsp;Seong Keun Kwon,&nbsp;Soyoung Lee,&nbsp;Jung Min Ko,&nbsp;Jong-Hee Chae,&nbsp;Dong In Suh","doi":"10.1089/ped.2021.0029","DOIUrl":"https://doi.org/10.1089/ped.2021.0029","url":null,"abstract":"<p><p><b><i>Background:</i></b> Myhre syndrome is a rare connective tissue disorder caused by heterozygous pathogenic variants in the <i>SMAD4</i> gene. Although recognizing Myhre syndrome in early childhood is challenging, it is important to manage airway stenosis in patients with Myhre syndrome. <b><i>Case Presentation:</i></b> We report the case of a 2-month-old boy who initially presented with severe multilevel airway stenosis, dysmorphic face, and multiple abnormalities. Lung fibrosis and mild aortic valve stenosis were additionally observed on follow-up examinations. A heterozygous missense variant, c.1499T>C (p.Ile500Thr), in <i>SMAD4</i> was identified through exome sequencing. Tracheostomy was performed, and the patient has maintained stable respiration through a customized tracheostomy tube with a home ventilator. <b><i>Conclusions:</i></b> Patients who have dysmorphic face, airway stenosis, and cardiovascular anomalies that do not fit the diagnosis of common syndromes should be evaluated for rare diseases, including Myhre syndrome. Since respiratory complications can be life threatening, early diagnosis and suitable intervention are necessary.</p>","PeriodicalId":54389,"journal":{"name":"Pediatric Allergy Immunology and Pulmonology","volume":"34 2","pages":"83-87"},"PeriodicalIF":0.9,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329727/pdf/ped.2021.0029.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39244195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Pediatric Allergy Immunology and Pulmonology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1